COUNTY HALL | LONDON | 20 April, 2023

WHY ATTEND?

MEET decision makers at leading and upcoming drug discovery and technology companies from the UK and Nordic regions, and investment firms throughout Europe.

LEARN from major investment firms about the current status of European investment in life science technologies.

GAIN insights from experienced life science operators within the Anglo-Nordic space.

Anglonordic has a 20-year tradition as an invitation-only gathering of investors and R&D growth companies that consistently offers unique opportunities for funding and collaboration.


Become a part of Anglonordic 2023: request your invitation now.

 

260 Attendees

71 Investor Firms

286 Partnering Meetings

26 Startup Pitches

WHO WILL YOU MEET?

Exclusively selected attendees will represent the following key drivers of the European life sciences growth sector:

  • CEOs, CSOs and Heads of Business Development from Emerging Life Science Companies in the Anglo-Nordic sphere and Continental Europe
  • Decision-makers from Europe's key Investor firms and Pharma companies
  • Key Supporters of the Life Science Ecosystem in Europe

Our 2022 event attracted an amazing total of 71 investment firms, with interests in a wide variety of technologies from small molecule discovery through protein technologies to AI applications and healthcare devices.